Senior insider sale
Chief Strategy & Dev. Officer at AGILON HEALTH, INC. — senior position signals high conviction
$5.52M
200K shares
What this filing means
DESAI VEERAL plans to sell 200K shares of AGILON HEALTH, INC. valued at approximately $5.52M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/20/2023ACC: 0001958244-23-000468
Officer· Chief Strategy & Dev. Officer
Since Apr 2021
200K
Shares to sell
$5.52M
Approx. market value
15K
Acquired (3 months)
1
Planned
4 completed
Securities Acquired — Last 3 Months1
Acquired as compensation -- stock options
Compensation -- cashless exercise / same-day sale
4/27/2017
15KTotal acquired15K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
4/27/2017 | Acquired as compensation -- stock options Compensation -- cashless exercise / same-day sale | 15K | — |
| Total | 15K | ||
Planned & Completed Dispositions5
Completed
—Completed
Units to sell
5K
Market value
$134.5K
4/19/2023
—Completed
Units to sell
97.29K
Market value
$2.79M
3/24/2023
—Completed
Units to sell
22.71K
Market value
$651.9K
3/23/2023
—Completed
Units to sell
60K
Market value
$1.57M
3/16/2023
Planned — Approximate Date
NYSEPlanned
Units to sell
15K
Market value
$373.9K
4/20/2023
Total
Units
200K
Value
$5.52M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
4/19/2023 | 5K | $134.5K | — | Completed |
3/24/2023 | 97.29K | $2.79M | — | Completed |
3/23/2023 | 22.71K | $651.9K | — | Completed |
3/16/2023 | 60K | $1.57M | — | Completed |
| Planned — Approximate Date | ||||
4/20/2023 | 15K | $373.9K | NYSE | Planned |
| Total | 200K | $5.52M | ||